CARDIOTOXICITY PHENOTYPES IN WOMEN TREATED WITH ANTHRACYCLINES AND TRASTUZUMAB FOR EARLY STAGE BREAST CANCER

被引：0
|
作者：
Nolan, Mark T. [1 ]
Selam, Mustafa Abdul [1 ]
Amir, Eitan [1 ]
Koch, Anne [1 ]
Yip, Paul [1 ]
Michalowska, Maria [1 ]
Wintersperger, Bernd [1 ]
Thavendiranathan, Paaladinesh [1 ]
机构：
[1] Peter Munk Cardiac Ctr, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)31406-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1186-557
引用
收藏
页码：799 / 799
页数：1
相关论文
共 50 条
  • [1] Cardiotoxicity Debated for Anthracyclines and Trastuzumab in Breast Cancer
    Brower, Vicki
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (12): : 835 - 836
  • [2] Trastuzumab cardiotoxicity in early-stage breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (06): : E226 - E226
  • [3] Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer
    Guenancia, Charles
    Ladoire, Sylvain
    Ghiringelli, Francois
    Rochette, Luc
    Vergely, Catherine
    Cottin, Yves
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2017, 110 (02) : 69 - 71
  • [4] Cardiotoxicity Associated Trastuzumab and Anthracyclines in Treating Breast Cancer Patients
    Al-Ali, Basheer Akeel
    Hatef, Zahraa S.
    Mohammed, Haithem Rauf
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (SI): : 135 - 140
  • [5] Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
    Luna-Alcala, Santiago
    Espejel-Guzman, Adrian
    Lerma, Claudia
    Leon, Paula
    Guerra, Enrique C.
    Espinosa Fernandez, Jose Rodrigo
    Martinez-Dominguez, Pavel
    Serrano-Roman, Javier
    Cabello-Ganem, Aldo
    Aparicio-Ortiz, Alexis D.
    Keirns, Candace
    Lerma, Abel
    Santa Ana-Bayona, Maria Jose
    Espinola-Zavaleta, Nilda
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [6] Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
    Espinola-Zavaleta, N.
    Luna-Alcala, S.
    Espejel-Guzman, A.
    Lerma, C.
    Leon, P.
    Guerra, E. C.
    Espinoza Fernandez, J. R.
    Martinez-Dominguez, P.
    Serrano-Roman, J.
    Cabello-Ganem, A.
    Aparicio-Ortiz, A. D.
    Keirns, C.
    Lerma, A.
    Santa Ana-Bayona, M. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [7] Role of metabolomics in the identification of early patterns of cardiotoxicity in patients with breast cancer treated with anthracyclines
    Pinna, Gabriele
    Aneris, Federico
    Agus, Elena
    Demelas, Roberta
    Peccianti, Antonella
    Pettinau, Antonio
    Zanda, Greca
    Noto, Antonio
    Fattuoni, Claudia
    Deidda, Martino
    Atzori, Francesco
    Madeddu, Clelia
    Scartozzi, Mario
    Mercuro, Giuseppe
    Dessalvi, Christian Cadeddu
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N19 - N20
  • [8] Defining the metabolomic profile associated with early cardiotoxicity in patients with breast cancer treated with anthracyclines
    Cocco, D.
    Ferro, E. G.
    Ricci, S.
    Deidda, M.
    Noto, A.
    Madeddu, C.
    Atzori, F.
    Scarlozzi, M.
    Mercuro, G.
    Dessalvi, C. Cadeddu
    EUROPEAN HEART JOURNAL, 2020, 41 : 3289 - 3289
  • [9] SERIAL ECHOCARDIOGRAPHY FOR EARLY DIAGNOSIS OF CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH TRASTUZUMAB
    Shah, F.
    Silverman, D.
    Doloto, P.
    Micetich, K. C.
    Barron, J. T.
    CARDIOLOGY, 2014, 128 : 417 - 417
  • [10] Cancer and Cardiovascular Disease: the Use of Novel Echocardiography Measures to Predict Subsequent Cardiotoxicity in Breast Cancer Treated with Anthracyclines and Trastuzumab
    Gulati G.
    Zhang K.W.
    Scherrer-Crosbie M.
    Ky B.
    Current Heart Failure Reports, 2014, 11 (4) : 366 - 373
12345